Case Reports in Dermatology · 2016 · 10 citations · 10 references
MedicineDermatologyPharmacologyPediatric Clinical PharmacologyPediatric DermatologyPediatric PharmacotherapyDrug-induced Skin ReactionsPediatric DermatopathologyDrug-induced PsoriasisInfantile PsoriasisNonselective Beta BlockersPropranolol TherapyPsoriasiform DermatitisPsoriasis TherapyPsoriatic Disease
Propranolol, a nonselective blocker of β-adrenergic receptors, has become the first-line treatment for complicated infantile hemangiomas. Therefore, its use in the pediatric population has expanded in recent years. In adults, β-blockers have been reported to be the most common causative agents for drug-induced psoriasis. In infants treated with propranolol for infantile hemangioma, the onset of psoriasiform diaper rash has not yet been reported. Here, to the best of our knowledge, we report the first case of psoriasiform diaper rash possibly induced by oral propranolol in an 18-month-old girl with no family history of psoriasis.
10
Epidemiology and comorbidity of psoriasis in children
Matthias Augustin, Gerd Glaeske, Marc Alexander Radtke et al. · British Journal of Dermatology · 2009 · 492 citations
Diagnosis and Management of Infantile Hemangioma
David H. Darrow, Arin K. Greene, Anthony J. Mancini et al. · PEDIATRICS · 2015 · 297 citations · Full text
The Burden of Childhood Psoriasis
Michelle E.A. de Jager, E.M.G.J. de Jong, Andrea W.M. Evers et al. · Pediatric Dermatology · 2011 · 86 citations